LIPIGON PHARMACEUTICALS AB revenue breakdown overview

LIPIGON PHARMACEUTICALS AB revenue for the last year amounted to 11.15 M SEK, the most of which — 10.29 M SEK — came from its highest performing source at the moment, Lipid-related Drugs, the year earlier bringing 16.41 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought LIPIGON PHARMACEUTICALS AB 10.29 M SEK, and the year before that — 16.41 M SEK.